Dashboard
Manage Tickers

CDNA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-initiates-coverage-on-caredx-with-underweight-rating-announces-price-target-of-28
Wells Fargo Initiates Coverage On CareDx w...
08/27/2024 21:54:27

Wells Fargo analyst Brandon Couillard initiates coverage on CareDx (NASDAQ:CDNA) with a Underweight rating and announces Pri...

what-4-analyst-ratings-have-to-say-about-caredx
What 4 Analyst Ratings Have To Say About C...
08/19/2024 14:00:15

btig-upgrades-caredx-to-buy-announces-40-price-target
BTIG Upgrades CareDx to Buy, Announces $40...
08/19/2024 13:22:26

BTIG analyst Sung Ji Nam upgrades CareDx (NASDAQ:CDNA) from Neutral to Buy and announces $40 price target.

caredx-announces-cms-retires-draft-policy-restricting-coverage-restoring-longstanding-coverage-for-allosure-allomap-and-heartcare-through-surveillance-testing-for-allograft-rejection
CareDx Announces CMS Retires Draft Policy ...
08/16/2024 18:11:24

goldman-sachs-maintains-buy-on-caredx-raises-price-target-to-26
Goldman Sachs Maintains Buy on CareDx, Rai...
08/01/2024 17:27:25

Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $16 to $26.

craig-hallum-maintains-buy-on-caredx-raises-price-target-to-32
Craig-Hallum Maintains Buy on CareDx, Rais...
08/01/2024 16:59:21

Craig-Hallum analyst Connor Chamberlain maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $22 to $32.

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
08/01/2024 13:48:38

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

why-carvana-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why Carvana Shares Are Trading Higher By 1...
08/01/2024 12:32:25

caredx-q2-2024-adj-eps-025-beats-014-estimate-sales-92274m-beat-67861m-estimate
CareDx Q2 2024 Adj. EPS $0.25 Beats $(0.14...
07/31/2024 20:37:50

CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.14) by 278...

where-caredx-stands-with-analysts
Where CareDx Stands With Analysts
07/17/2024 16:00:38

goldman-sachs-maintains-buy-on-caredx-raises-price-target-to-16
Goldman Sachs Maintains Buy on CareDx, Rai...
07/17/2024 16:00:00

Goldman Sachs analyst Matthew Sykes maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $14 to $16.

decoding-6-analyst-evaluations-for-caredx
Decoding 6 Analyst Evaluations For CareDx
05/31/2024 18:01:19

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
05/31/2024 17:52:10

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

caredx-to-present-new-data-at-the-2024-american-transplant-congress-being-held-june-1-5-in-philadelphia
CareDx To Present New Data At The 2024 Ame...
05/30/2024 11:28:22

CareDx solutions are featured in 36 oral presentations and posters, and a symposium. The findings highlight innovative approach...

Core News & Articles
CareDx Informed Natera And The Court, Sinc...
05/29/2024 12:31:22

CareDx Reiterates Position that it Does Not Infringe Natera's ‘544 Patent Injunction Motion has No Impact on CareDx's ...

top-3-health-care-stocks-that-may-crash-in-may
Top 3 Health Care Stocks That May Crash In...
05/24/2024 11:53:28

craig-hallum-maintains-buy-on-caredx-raises-price-target-to-22
Craig-Hallum Maintains Buy on CareDx, Rais...
05/17/2024 12:09:14

Craig-Hallum analyst Connor Chamberlain maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $15 to $22.

caredx-presents-findings-from-the-shore-study-heartcare-outperforms-dd-cfdna-alone-in-identifying-rejection-and-patients-experienced-fewer-biopsies
CareDx Presents Findings from The SHORE St...
05/16/2024 20:24:00

HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular RejectionCardiologists Performed the Fewes...

hc-wainwright--co-reiterates-neutral-on-caredx
HC Wainwright & Co. Reiterates Neutral on ...
05/15/2024 15:32:55

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral.

navigating-5-analyst-ratings-for-caredx
Navigating 5 Analyst Ratings For CareDx
05/13/2024 21:00:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION